Table 2.
Recent viral load | No recent viral load | P | |
---|---|---|---|
ART initiations prior to April 2010, n | 456 | 565 | |
Facility catchment population, n (%) | 0·001* | ||
≤5000 | 9 (3·3%) | 23 (4·6%) | |
5000–10 000 | 123 (45·4%) | 159 (31·6%) | |
>10 000 | 139 (51·3%) | 321 (63·8%) | |
Gender, n (%) | 0·909 | ||
Male | 226 (49·6%) | 278 (49·2%) | |
Female | 230 (50·4%) | 287 (50·8%) | |
Time on treatment, years, median (range) | 6·3 (4·7–9·9) | 6·1 (4·7–9·9) | 0·514 |
Current age, years, median (range) | 11·7 (5·2–22·8) | 11·9 (4·9–22·9) | 0·419 |
ART initiations between April 2010 and August 2012, n | 554 | 663 | |
Facility catchment population, n (%) | <0·001† | ||
≤5000 | 26 (6·9%) | 24 (4·1%) | |
5000–10 000 | 209 (55·7%) | 219 (37·4%) | |
>10 000 | 140 (37·3%) | 342 (58·5%) | |
Gender, n (%) | 0·041 | ||
Male | 295 (53·3%) | 314 (47·4%) | |
Female | 259 (46·8%) | 349 (52·6%) | |
Time on treatment, years, median (range) | 3·4 (2·3–4·7) | 3·5 (2·3–4·7) | 0·063 |
Current age, years, median (range) | 9·4 (2·6–19·4) | 8·8 (2·6–18·5) | 0·109 |
ART initiations after August 2012, n | 423 | 621 | |
Facility catchment population, n (%) | 0·006‡ | ||
≤5000 | 20 (6·3%) | 16 (2·8%) | |
5000–10 000 | 159 (50·2%) | 263 (45·5%) | |
>10 000 | 138 (43·5%) | 299 (51·7%) | |
Gender, n (%) | 0·804 | ||
Male | 199 (47·0%) | 297 (47·8%) | |
Female | 224 (53·0%) | 324 (52·2%) | |
Time on treatment, years, median (range) | 1·3 (0·5–2·3) | 1·4 (0·5–2·3) | 0·573 |
Current age, years, median (range) | 7·4 (0·7–16·8) | 6·7 (0·6–17·0) | 0·093 |
ART, Antiretroviral therapy.
Statistically significant differences are shown in bold.
Significant difference between the 5000–10 000 and >10 000 groups (P < 0·001).
Significant difference between the 5000–10 000 and >10 000 groups (P < 0·001) and the ≤5000 and >10 000 groups (P = 0·001).
Significant difference between the ≤5000 and >10 000 groups (P = 0·003) and the ≤5000 and 5000–10 000 groups (P = 0·035).